company background image
ICLR logo

ICON NasdaqGS:ICLR Stock Report

Last Price

US$331.77

Market Cap

US$27.5b

7D

-0.6%

1Y

31.1%

Updated

24 Jul, 2024

Data

Company Financials +

ICON Public Limited Company

NasdaqGS:ICLR Stock Report

Market Cap: US$27.5b

ICLR Stock Overview

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

ICLR fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance5/6
Financial Health4/6
Dividends0/6

ICON Public Limited Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for ICON
Historical stock prices
Current Share PriceUS$331.77
52 Week HighUS$347.72
52 Week LowUS$221.20
Beta1.23
11 Month Change4.71%
3 Month Change10.56%
1 Year Change31.08%
33 Year Change44.08%
5 Year Change112.44%
Change since IPO5,116.92%

Recent News & Updates

ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)

Jul 13

Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)

Jun 14
Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)

Recent updates

ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)

Jul 13

Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)

Jun 14
Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)

Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching

May 30
Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching

ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet

May 14
ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet

ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next

Apr 28
ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next

What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?

Apr 21
What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?

ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price

Apr 05
ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price

ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump

Mar 05
ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump

With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

Feb 07
With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?

Feb 01

These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Jan 23
These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

Jan 08
Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E

Dec 24
What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E

A Look At The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

Dec 09
A Look At The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

Nov 08
With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case

Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching

Oct 09
Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching

Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Sep 23
Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

Sep 05
Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

Does ICON (NASDAQ:ICLR) Deserve A Spot On Your Watchlist?

Aug 03
Does ICON (NASDAQ:ICLR) Deserve A Spot On Your Watchlist?

Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

Jun 30
Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?

Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Jun 12
Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

May 23
Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)

Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

Mar 29
Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?

Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Mar 11
Is ICON (NASDAQ:ICLR) Using Too Much Debt?

Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 28%?

Feb 21
Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 28%?

Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching

Dec 28
Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching

These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Dec 10
These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well

Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 26% Discount?

Nov 22
Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 26% Discount?

Icon selected by BARDA to conduct anthrax vaccine clinical trial

Oct 06

Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?

Sep 15
Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?

ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly

Aug 26
ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly

Baron Funds - ICON Plc: Positioned For An Extended Period Of Revenue And Earnings Growth

Aug 11

Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 41%?

Aug 01
Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 41%?

Icon Q2 2022 Earnings Preview

Jul 26

ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet

May 11
ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet

ICON Public Limited Company (NASDAQ:ICLR) Shares Could Be 30% Below Their Intrinsic Value Estimate

Apr 20
ICON Public Limited Company (NASDAQ:ICLR) Shares Could Be 30% Below Their Intrinsic Value Estimate

Is There Now An Opportunity In ICON Public Limited Company (NASDAQ:ICLR)?

Feb 16
Is There Now An Opportunity In ICON Public Limited Company (NASDAQ:ICLR)?

We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt

Jan 26
We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt

Shareholder Returns

ICLRUS Life SciencesUS Market
7D-0.6%-0.8%-1.6%
1Y31.1%-4.8%19.8%

Return vs Industry: ICLR exceeded the US Life Sciences industry which returned -4.8% over the past year.

Return vs Market: ICLR exceeded the US Market which returned 19.8% over the past year.

Price Volatility

Is ICLR's price volatile compared to industry and market?
ICLR volatility
ICLR Average Weekly Movement3.6%
Life Sciences Industry Average Movement7.9%
Market Average Movement5.9%
10% most volatile stocks in US Market14.8%
10% least volatile stocks in US Market2.9%

Stable Share Price: ICLR has not had significant price volatility in the past 3 months.

Volatility Over Time: ICLR's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199041,150Steve Cutlerwww.iconplc.com

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization.

ICON Public Limited Company Fundamentals Summary

How do ICON's earnings and revenue compare to its market cap?
ICLR fundamental statistics
Market capUS$27.47b
Earnings (TTM)US$683.12m
Revenue (TTM)US$8.23b

40.2x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ICLR income statement (TTM)
RevenueUS$8.23b
Cost of RevenueUS$5.79b
Gross ProfitUS$2.44b
Other ExpensesUS$1.76b
EarningsUS$683.12m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 25, 2024

Earnings per share (EPS)8.26
Gross Margin29.69%
Net Profit Margin8.30%
Debt/Equity Ratio37.1%

How did ICLR perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.